CD4 and neoplasm: Moreover, in a subcutaneous transplantation tumor mouse model, the depletion of CD4+ T cells in mice using anti-CD4 Ab alongside anti-CD47 Ab therapy significantly diminished the effect of anti-CD47 Ab in promoting tumor vascular normalization.